| Dissociation constant, pKa of the compound - BioAssay Summary An oral, peripherally restricted CB1/CB2 agonist could provide an interesting approach to treat chronic pain by harnessing the analgesic properties of cannabinoids but without the well-known central side effects. ##-Carbolines are a novel class of potent mixed CB1/CB2 agonists characterized by attractive physicochemical properties including high aqueous solubility. Optimization of the series has led to the discovery of 29, which has oral activity in a rat inflammatory pain model and limited brain exposure at analgesic doses, consistent with a lower risk of CNS-mediated tolerability issues. ..more |
_ | |
||||||||||||||||||||||||||||||||||||||||||||||||
Tested Compounds: Description: Title: ##-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration. Abstract: An oral, peripherally restricted CB1/CB2 agonist could provide an interesting approach to treat chronic pain by harnessing the analgesic properties of cannabinoids but without the well-known central side effects. ##-Carbolines are a novel class of potent mixed CB1/CB2 agonists characterized by attractive physicochemical properties including high aqueous solubility. Optimization of the series has led to the discovery of 29, which has oral activity in a rat inflammatory pain model and limited brain exposure at analgesic doses, consistent with a lower risk of CNS-mediated tolerability issues. (PMID: 22284817) Comment Putative Target: ChEMBL Target ID: 22226 Target Type: UNCHECKED Pref Name: Unchecked Confidence: Default value - Target unknown or has yet to be assigned Relationship Type: Default value - Target has yet to be curated Categorized Comment ChEMBL Assay Type: Unassigned ChEMBL Assay Data Source: Scientific Literature Result Definitions
Data Table (Concise)
PageFrom: |
||||||||||||||||||||||||||||||||||||||||||||||||||